Jane Street’s Psyence Biomedical PBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$88.7K Sell
16,240
-14,191
-47% -$58.1K ﹤0.01% 10679
2026
Q2
$93.1K Buy
+30,431
New +$138K ﹤0.01% 10635
2024
Q4
– Sell
-12
Closed -$4.6K – 10785
2024
Q3
$4.6K Buy
+12
New +$16.2K ﹤0.01% 9408

Other funds holding PBM

Jane Street's PBM Position: Q3 2026 in Review

Jane Street reduced its Psyence Biomedical (PBM) stake by 47% in Q3 2026, selling an estimated $58.1K and leaving 16,240 shares worth $88.7K. The position accounts for ﹤0.01% of the portfolio, ranked #10679.

Jane Street first reported a position in PBM in Q3 2024 and has held it in 3 quarters since. The position peaked at $93.1K in Q2 2026. 10 funds tracked by Wall St. Rank hold PBM as of Q3 2026.

  • Jane Street held 16,240 shares of Psyence Biomedical worth $88.7K as of Q3 2026.
  • Jane Street sold 14,191 Psyence Biomedical shares in Q3 2026, an estimated $58.1K.
  • Psyence Biomedical made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #10679 holding.
  • Jane Street first reported a position in Psyence Biomedical in Q3 2024 and has held it in 3 quarters since.
  • Jane Street's Psyence Biomedical position peaked at $93.1K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Psyence Biomedical as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.